Sundar PichaiSundar Pichai earned $164M in 2023

Javier J. Rodriguez has been the CEO of DaVita Inc. since June 2019, bringing years of experience in the healthcare sector. He started his career at DaVita in 1998 and steadily moved up the ranks. Over his journey, he served...

Quick Links
D

Javier J. Rodriguez

CEO of DaVita

Field of Expertise

Healthcare & Life Sciences - Healthcare

Sector of Economy

Healthcare

Born

November 30, 1969 - 55 years ago

CEO of DaVita for

5 years 10 months (Jun 2019 - Present)

Previous Experience

Chief Executive Officer of DaVita Kidney Care since March 2014; President from February 2012 to March 2014

Holdings

See how much did Javier J. Rodriguez make over time.

Javier J. Rodriguez has seen significant changes in his holdings since becoming CEO. His insider trading activities show a notable increase in value, particularly in early 2024, where his stock reached over $138 million. This surge represents a strategic approach...

Mar 17, 2025

Total Stock Sold

$64.06M

DVA

$64.05M

944,513 DVA shares

GILD

$14.18K

189 GILD shares

What if they kept their stock?

If Javier J. Rodriguez didn't sell their stock, today they would have:
Extra DVA944,513 shares worth $72.69M and GILD189 shares worth $14.17K.
This is 13.49% and $8.64M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Javier J. Rodriguez.

DVA

37,423 shares

DVA

Nov 15, 2024

Received

DVA

$9.82M

DVA at $163.95/share

Sep 13, 2024

Sale

DVA

$6.26M

DVA at $155.93/share

Aug 26, 2024

Sale

GILD

2,310 shares

GILD

May 8, 2024

Received

DVA

$9.49M

DVA at $126.49/share

Feb 26, 2024

Sale

DVA

$1.69M

DVA at $99.71/share

May 10, 2023

Sale

DVA

58,780 shares

DVA

May 10, 2023

Received

GILD

1,887 shares

GILD

May 3, 2023

Received

DVA

24,890 shares

DVA

May 12, 2022

Received

GILD

2,444 shares

GILD

May 5, 2022

Received

Compensation History

See how much did Javier J. Rodriguez make over time.

In 2022, Javier J. Rodriguez’s total compensation was $2,984,581, primarily driven by his annual salary of $1,200,000. This marked a stable figure in his pay structure, as he did not receive bonuses or stock grants, underscoring DaVita's focus on performance-related pay. In previous years, such as 2020, his total compensation was notably higher at around $130 million, which included substantial vested stock options. This model reflects DaVita’s compensation philosophy aimed at aligning executive performance with shareholder interests, where outstanding performance metrics directly influence pay. His compensation structure is designed to enhance accountability and commitment to long-term strategic objectives, which is crucial in a competitive healthcare landscape.

Year

2022

Total Compensation

$1.81M

Salary

$1.20M

Board Justification

The compensation philosophy emphasizes performance-based pay, aligning executive interests with stockholder value, and includes rigorous performance metrics tied to financial and ESG goals.

Bonus

$0.00

Board Justification

No bonus was awarded for the year 2022.

Other

$610.78K

Board Justification

Other compensation includes benefits such as health insurance and retirement contributions.

Restricted Stock

$0.00(0 SSAR)

Board Justification

No stock awards vested in 2022 as Mr. Rodriguez did not receive any stock grants in 2022 due to the CEO Premium-Priced SSAR Award granted in 2019, which covers five years of awards through 2024.

Performance Metrics

Adjusted Earnings per Share, Free Cash Flow, and Total Shareholder Return.

Other DaVita CEOs

Here are other CEOs of DaVita